TOKYO--(BUSINESS WIRE)--Asia's largest bio event held annually in Tokyo: INT'L BIO FORUM & BIO
EXPO JAPAN will be renewed as "BIO
tech 2012", moving to April 25th through 27th.
What's
new about BIO tech 2012?
Fulfilling each of the 3 pillars:
"Partnering", "Conference" and "Exhibition" more than ever, this event
secures its position as the central hub of the latest information and
new business opportunities in the Asian bio industry.
|
< 1 > Partnering: |
| Largest number of academic participants ever! |
| The number of universities & research institutes presenting their latest platform technologies will be doubled from the previous year (300 participants expected). |
| In addition to these academics, a large number of biotech companies, pharma companies and investors are to participate in "Bio Partnering System", where licensing and collaborative research are generated. |
| Also, major pharmaceutical companies as below are taking part in Bio Partnering System as Pharma Company Sponsors: |
| AJINOMOTO PHARMACEUTICALS, Astellas Pharma, AstraZeneca, Chugai Pharmaceutical, DAIICHI SANKYO, Dainippon Sumitomo Pharma, Eli Lilly Japan, F. Hoffmann-La Roche, JANSSEN PHARMACEUTICAL, KAKEN PHARMACEUTICAL, KYORIN Pharmaceutical, Meiji Seika Pharma, Mitsubishi Tanabe Pharma, NIPPON SHINYAKU, NOVARTIS PHARMA, sanofi-aventis, Takeda Pharmaceutical |
| (as of February 3, in alphabetical order) |
| < 2 > Conference: |
| Advisory Committee has been reshuffled! Japanese top researchers have pledged their whole-hearted support for BIO tech 2012. |
| This results in even more substantial conference with 350 sessions inviting authorities of each field from home and abroad, which will attract around 6000 participants. |
| Including hot topics like Vaccine, iPS/ES cells, IT-based drug design or Plant Genome, everything on the Asian life science industry will be revealed here. |
| For this year's Keynote Session, below speakers will address about "New Trends of Next-generation Biotechnology & Pharmaceutical Development". |
| - | Mr. John W. Shiver, Vice President, Vaccines Discovery, Merck Research Labs. | |
| - | Mr. Tatsuhiko Kodama, Professor, Dept. of System Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo | |
| - | Mr. Anand Mushesh Gautam, Director, Biopharmaceutical Sourcing, Biopharmaceutical Research Unit, Novo Nordisk A/S | |
|
< 3 > Exhibition: |
| The number of overseas exhibitors and visitors will greatly increase! BIO tech 2012 becomes more international than ever. |
| By staggering show dates with respect to large-scale events in Europe and the US, an increasing number of overseas exhibitors are joining BIO tech again or anew, intending to set it as the base for their business expansion in Asia. Leading companies such as Merck, Sanofi-aventis, etc. will exhibit as well. |
|
For more information on BIO tech 2012, please visit www.bio-t.jp/en/ |
| We are looking forward to seeing you at BIO tech 2012, starting from April 25th. |
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50179454&lang=en